Add Company
Join Now

Neumedicines Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Neumedicines's estimated annual revenue is currently $1.9M per year.(i)
  • Neumedicines's estimated revenue per employee is $155,000

Employee Data

  • Neumedicines has 12 Employees.(i)
  • Neumedicines grew their employee count by -8% last year.

Neumedicines's People

NameTitleEmail/Phone
1
Chairman/CEO/FounderReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
VP, Drug DevelopmentReveal Email/Phone
4
Sr. Director Quality and GMP OperationsReveal Email/Phone
5
Member Board DirectorsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Neumedicines?

Neumedicines Inc. is an emerging therapeutic biotechnology company focused on developing and commercializing innovative and proprietary products and approaches that address unmet clinical and societal needs in the areas of oncology, hematology, and immunology. The company operates from its headquarters in Pasadena, California. Neumedicines' lead product candidate is recombinant human interleukin-12 (rHuIL-12), a heterodimeric glycoprotein and cytokine. rHuIL-12 is being developed under the trade name HemaMaxâ„¢ for various clinical indications, including hematopoietic syndrome of acute radiation syndrome (HSARS), skin cancers and other solid tumors, and blood disorders and malignancies.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M129%N/A
#2
$1.9M120%N/A
#3
$1.8M1250%N/A
#4
$1.5M1220%N/A
#5
$1.9M12-45%N/A